Stock Research: Repligen

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Repligen

NSQ:RGEN US7599161095
42
  • Value
    14
  • Growth
    48
  • Safety
    Safety
    92
  • Combined
    46
  • Sentiment
    41
  • 360° View
    360° View
    42
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Repligen Corporation develops and commercializes bioprocessing technologies and systems for the life sciences industry. It focuses on Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins. Its products are used in process development, manufacturing, and quality control of biological drugs. In the last fiscal year, the company had a market cap of $6737 million, profits of $319 million, and revenue of $634 million, with 1778 employees.

more

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock Repligen are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Repligen. The only rank that is above average is the consolidated Safety Rank at 92, which means that the company has a financing structure that is safer than those of 92% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 14, which means that the share price of Repligen is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 48, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 41, which means that professional investors are more pessimistic about the stock than for 59% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
NASDAQ
D.J. US Health Care
S&P MIDCAP
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
14 6 1 5
Growth
48 65 33 49
Safety
Safety
92 88 78 67
Sentiment
41 65 96 95
360° View
360° View
42 77 57 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
37 51 74 66
Opinions Change
27 50 72 35
Pro Holdings
n/a 37 66 97
Market Pulse
19 77 78 80
Sentiment
41 65 96 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
14 6 1 5
Growth
48 65 33 49
Safety Safety
92 88 78 67
Combined
46 71 22 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
42 13 9 29
Price vs. Earnings (P/E)
10 5 12 6
Price vs. Book (P/B)
48 37 37 37
Dividend Yield
1 1 1 1
Value
14 6 1 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
55 59 27 55
Profit Growth
82 32 21 88
Capital Growth
43 80 55 4
Stock Returns
24 47 69 59
Growth
48 65 33 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
41 51 47 50
Refinancing
87 35 23 27
Liquidity
73 88 98 72
Safety Safety
92 88 78 67

Similar Stocks

Discover high‑ranked alternatives to Repligen and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only above-average rank is Safety. All other ranks (Value, Growth, and Sentiment) are below average. As Safety is the least critical rank, there are few positive facts to support this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: